Conclusion
our study showed that pharmacist-driven ASP in febrile neutropenic
patients could improve antibiotic appropriateness in both empirical and
documentation therapy. However, 30-day infectious diseases-related
mortality and length of stay were not different between the groups.
Although target antibiotic utilization in the intervention group
increased, we found a reduction in total antibiotic utilization in the
pharmacist-driven ASP group.
Acknowledgements: We thank the primary physicians who
practicing in the medical wards during study period at Thammasat
University Hospital.
Funding: No financial support was provided relevant to this
article.
Data availability statement: The data that support the findings
of this study are available on request from the corresponding author.
The data are not publicly available due to privacy or ethical
restrictions.